Survey on the perception and current status of drug risk management in medical institutions

SUN Xuelin; XING Mingqing; ZHANG Zixuan; ZHAO Wenjing; QIAN Dongfang; LIANG Yan; XU Li; JIN Pengfei; ZHANG Yatong

doi:10.6039/j.issn.1001-0408.2025.01.02

您当前的位置：

首页 >

文章列表页 >

Survey on the perception and current status of drug risk management in medical institutions

更新时间：2025-09-25

- Survey on the perception and current status of drug risk management in medical institutions
- ZHONGGUO YAOFANG Vol. 36, Issue 1, Pages: 7-12(2025)
- 作者机构：
  
  1.北京医院药学部/国家老年医学中心/中国医学科学院老年医学研究院，北京　100730
  2.青岛市市立医院医学检验部，山东青岛　266001
  3.北京北方医药健康经济研究中心，北京　100021
  4.解放军总医院医疗保障中心药剂科派驻第三医学中心药剂室，北京　100089
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.01.02
  CLC： R95;R969.3
- Received：05 July 2024，
  
  Revised：2024-11-15，
  
  Accepted：18 November 2024，
  
  Published：15 January 2025
- 稿件说明：
移动端阅览
孙雪林,邢明青,张子轩,等.医疗机构药品风险管理认知与现状调研[J].中国药房,2025,36(01):7-12.

SUN Xuelin,XING Mingqing,ZHANG Zixuan,et al.Survey on the perception and current status of drug risk management in medical institutions[J].ZHONGGUO YAOFANG,2025,36(01):7-12.
孙雪林,邢明青,张子轩,等.医疗机构药品风险管理认知与现状调研[J].中国药房,2025,36(01):7-12. DOI： 10.6039/j.issn.1001-0408.2025.01.02.

SUN Xuelin,XING Mingqing,ZHANG Zixuan,et al.Survey on the perception and current status of drug risk management in medical institutions[J].ZHONGGUO YAOFANG,2025,36(01):7-12. DOI： 10.6039/j.issn.1001-0408.2025.01.02.

摘要

目的

了解我国医疗机构药学人员在药品使用过程中对药品风险管理工作的认知和现状，为促进医疗机构药品风险管理体系的完善与发展提供经验和建议。

方法

采用问卷调查法，面向全国28个省（区、市），采用分层随机抽样，以全国医疗机构的医务工作者、医疗相关药学从业人员群体为研究对象，调查内容包括调查人群信息，医疗机构药品风险管理实施现状，药品风险管理相关概念的认知、含义与流程，医疗机构药品风险管理工作内容及模式；最后，收集完善医疗机构药品风险管理体系建设的建议。采用描述性统计分析对所得数据进行汇总。

结果

本次调研共回收问卷446份，其中有效问卷420份，无效问卷26份，问卷回收率为100%，有效率为94.17%。51.19%的参研人员对医疗机构药品风险管理认知来源于《药品不良反应报告和监测管理办法》；87.38%的参研人员支持医疗机构药品风险管理的管理范围包括药品使用的全流程。63.33%的参研人员表示自己所在医疗机构设立了医疗机构药品风险管理相关岗位，其中三级甲等及以上医疗机构占比最高（72.17%）。66.43%的参研人员反馈在药品使用全部环节均进行药品风险管理。参研人员针对医疗机构药品风险管理体系发展的建议重点集中在完善制度指导性文件、明确概念内涵、建立信息共享机制等方面。

结论

目前我国医疗机构药品风险管理总体认知水平较高，其工作正在多环节、多形式地实施开展，但仍需加强相关制度文件、管理规范和体系建设，进一步完善信息共享机制，促进风险管理的社会共治和协作，提高药品管理水平，保障患者用药安全。

Abstract

OBJECTIVE

To know about the perception and current status of drug risk management among pharmacists in Chinese medical institutions， providing insights and recommendations for enhancing the drug risk management system in medical institutions.

METHODS

A questionnaire survey was conducted across 28 provinces， cities， and autonomous regions； stratified radom sampling was employed to study the population of medical workers and pharmaceutical professionals in medical institutions nationwide. The survey included information on the survey population， the current status of drug risk management implementation in medical institutions， the cognition， definition and process of drug risk management related concepts， and the content and mode of drug risk management work in medical institutions. Finally， suggestions were collected from various medical institutions on the system construction of drug risk management. Descriptive statistical analysis was adopted to summarize the obtained data.

RESULTS

A total of 446 questionnaires were collected in this survey， including 420 valid questionnaires and 26 invalid questionnaires. The questionnaire collection rate was 100%， and the effective rate was 94.17%. 51.19% of the respondents based their understanding of drug risk management on

Management Measures for Adverse Drug Reaction Reports and Monitoring

， while 87.38% recognized the need for drug risk management throughout the drug use process. 63.33% of the participants stated that their medical institutions had dedicated positions related to drug risk management， with the highest proportion （72.17%） was in third-grade class A medical institutions. 66.43% reported implementing risk ma

nagement across all drug use stages. Suggestions for the development of drug risk management systems in medical institutions by the research participants focused on enhancing guiding documents， clarifying concepts， establishing information-sharing mechanisms.

CONCLUSIONS

The overall awareness of drug risk management in China’s medical institutions is high， with practices in place across various stages in multiple forms. However， there remains a need to strengthen institutional documents， management regulations， system development， and information-sharing mechanisms to improve collaborative governance， improve drug management levels， and ensure patient safety.

关键词

Keywords

references

全国人民代表大会常务委员会 . 中华人民共和国药品管理法 [EB/OL ] . （ 2019-08-27 ）[ 2024-01-10 ] . https：//www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html .

National People’s Congress Standing Committee . Pharmaceutical administration law of the people’s republic of China [EB/OL ] .（ 2019-08-27 ）[ 2024-01-10 ] . https：//www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html .

国家药品监督管理局药品评价中心 . 风险识别、评估与控制 [M ] . 北京：中国医药科技出版社， 2022 ： 6 .

National Medical Products Administration’s Drug Evaluation Center . Risk identification，assessment and control [M ] . Beijing ： China Medical Science and Technology Press ， 2022 ： 6 .

国家卫生健康委，教育部，财政部，等 . 关于加强医疗机构药事管理促进合理用药的意见 [EB/OL ] .（ 2020-02-21 ）[ 2024-07-01 ] . https：//www.gov.cn/gongbao/content/2020/content_5522549.htm?ivk_sa=1024320u https://www.gov.cn/gongbao/content/2020/content_5522549.htm?ivk_sa=1024320u .

National Health Commission，Ministry of Education，Mi- nistry of Finance，et al . Opinions on strengthening the pharmaceutical administration of medical institutions and promoting rational drug use [EB/OL ] .（ 2020-02-21 ）[ 2024-07-01 ] . https：//www.gov.cn/gongbao/content/2020/content_5522549.htm?ivk_sa=1024320u https://www.gov.cn/gongbao/content/2020/content_5522549.htm?ivk_sa=1024320u .

龚时薇，张亮，黄杰敏，等 . 药品安全与风险管理 [J ] . 中国药房， 2007 ， 18 （ 22 ）： 1687 - 1690 .

GONG S W ， ZHANG L ， HUANG J M ， et al . Drug safety and drug risk management [J ] . China Pharm ， 2007 ， 18 （ 22 ）： 1687 - 1690 .

孙雪林，胡欣，钱东方，等 . 医疗机构药品使用风险管理研究进展 [J ] . 中国食品药品监管， 2024 （ 1 ）： 44 - 53 .

SUN X L ， HU X ， QIAN D F ， et al . Research progress on risk management of drug utilization in healthcare institutions [J ] . China Food Drug Adm Mag ， 2024 （ 1 ）： 44 - 53 .

孙雪林，钱东方，张亚同，等 . 建设我国药品使用风险管理体系的探讨 [J ] . 中国药物评价， 2021 ， 38 （ 6 ）： 499 - 503 .

SUN X L ， QIAN D F ， ZHANG Y T ， et al . Discussion on the construction of risk management system of drug use in China [J ] . Chin J Drug Eval ， 2021 ， 38 （ 6 ）： 499 - 503 .

张博全，赵珊珊，刘水，等 . 应对突发事件救援药品准备数据库的设计与实现 [J ] . 中华灾害救援医学， 2021 ， 9 （ 5 ）： 961 - 965，1017 .

ZHANG B Q ， ZHAO S S ， LIU S ， et al . Design and implementation of drug preparation database for emergency response [J ] . Chin J Disaster Med ， 2021 ， 9 （ 5 ）： 961 - 965，1017 .

司倩，林丽开，陈楠 . 中国医疗机构高警示药品风险管理指南计划书 [J ] . 药物流行病学杂志， 2023 ， 32 （ 8 ）： 841 - 848 .

SI Q ， LIN L K ， CHEN N . Protocol for the development of guidelines for risk management of high alert medications in Chinese medical institutions [J ] . Chin J Pharmacoepidemiol ， 2023 ， 32 （ 8 ）： 841 - 848 .

李莹，刘敏，乐凯迪，等 . 医疗机构新型抗肿瘤药物临床应用管理模式探讨 [J ] . 中国医院用药评价与分析， 2024 ， 24 （ 2 ）： 137 - 139 .

LI Y ， LIU M ， LE K D ， et al . Exploration on management mode of clinical application of new anti-tumor drugs in medical institutions [J ] . Eval Anal Drug Use Hosp China ， 2024 ， 24 （ 2 ）： 137 - 139 .

陈慧，苏广全，刘晓，等 . 中国医疗机构药品目录管理评价指南 [J ] . 中国药房， 2022 ， 33 （ 6 ）： 641 - 652 .

CHEN H ， SU G Q ， LIU X ， et al . Guideline for the evaluation of medicine list in Chinese medical institutions [J ] . China Pharm ， 2022 ， 33 （ 6 ）： 641 - 652 .

刘福梅，王连心，谢雁鸣 . 中药安全性信号早期发现与风险管控 [J ] . 中国中药杂志， 2021 ， 46 （ 21 ）： 5456 - 5461 .

LIU F M ， WANG L X ， XIE Y M . Early detection and risk control of safety signals of Chinese medicine [J ] . China J Chin Mater Med ， 2021 ， 46 （ 21 ）： 5456 - 5461 .

MCGOWAN J ， WOJAHN A ， NICOLINI J R . Risk manage- ment event evaluation and responsibilities [M ] . San Francisco ： StatPearls Publishing ， 2023 ： 3 .

李幼平，文进，王莉 . 药品风险管理：概念、原则、研究方法与实践 [J ] . 中国循证医学杂志， 2007 ， 7 （ 12 ）： 843 - 848 .

LI Y P ， WEN J ， WANG L . Risk management of drugs：concepts，principles，methodology and practice [J ] . Chin J Evid Based Med ， 2007 ， 7 （ 12 ）： 843 - 848 .

Views

205

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Construction of the management index system for the management of off-label drug use in the hospital based on Delphi method

Analysis of the working model of pharmacy consultation in medical institutions in China： a scoping review

Review and comment rules of national key monitoring drug prescriptions （medical orders）

Principles for the rational use of national key monitoring drugs （the second batch）

Guideline for the prevention and control of occupational exposure risks to cytotoxic drugs in medical institutions

Related Author

LIU Li

Zebi

Danzenglaji

LIU Rui

WANG Feng

HU Yang

ZUO Wei

LIU Xiaoxia

Related Institution

Dept. of Pharmacy， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences

Dept. of Medical Administration， People’s Hospital of Xizang Autonomous Region

Dept. of Pharmacy， People’s Hospital of Xizang Autonomous Region

Dept. of Pharmacy， the Affiliated Hospital of Qingdao University

Dept. of Pharmacy， Guizhou Hospital of the First Affiliated Hospital， Sun Yat-sen University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰